Cabergoline

Active ingredient description

Cabergoline is a dopaminergic ergoline derivative endowed with a potent and long-lasting PRL-lowering activity.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Cabergoline
G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors
Discover more medicines within G02CB03
Cabergoline
N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC06

Medicines

Cabergoline is the active ingredient of these drugs:

Drug
Countries

Italy

Brazil

Australia Finland Ireland United Kingdom

Austria Germany

Brazil

Tunisia

Brazil

Australia Austria Brazil Cyprus Finland

Tunisia

Tunisia

Spain

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

LL60K9J05T - CABERGOLINE

CAS registry number

81409-90-7 - cabergoline

SNOMED-CT

386979007 - Cabergoline (substance)